Subcutaneous levetiracetam for the management of seizures at the end of life
AE Sutherland, J Curtin, V Bradley, O Bush… - BMJ Supportive & …, 2018 - spcare.bmj.com
Objectives To report the results of a combined case series analysis of subcutaneous
levetiracetam (Keppra) for the management of seizures in palliative care patients. Methods A …
levetiracetam (Keppra) for the management of seizures in palliative care patients. Methods A …
Nutritional risk in hospitalised children: an assessment of two instruments
RE Ling, V Hedges, PB Sullivan - e-SPEN, the European e-Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: A child's nutritional status may deteriorate over the course of a
hospital admission. No universally accepted paediatric nutritional screening tool exists. This …
hospital admission. No universally accepted paediatric nutritional screening tool exists. This …
P-73 Case report: subcutaneous tranexamic acid administration via a continuous infusion successfully controlled bleeding at end of life
R Hogg, V Hedges, C Bond, M Miller, M Presland - 2022 - spcare.bmj.com
Background Bleeding at the end of life is distressing. The use of enteral and intravenous
tranexamic acid (TA) to manage bleeding is established. The delivery of TA via continuous …
tranexamic acid (TA) to manage bleeding is established. The delivery of TA via continuous …
81 A qualitative study of family carer experience of anticipatory prescribing of injectable medications for end of life care at home
V Hedges, B Wee, C Bond - 2021 - spcare.bmj.com
Background Healthcare professionals believe that anticipatory prescribing of injectable
medications provides reassurance, improves symptom control and prevents hospital …
medications provides reassurance, improves symptom control and prevents hospital …
P-63 Subcutaneous levetiracetam for the management of seizures at the end of life
A Sutherland, J Curtin, V Bradley… - BMJ Supportive & …, 2017 - spcare.bmj.com
Background Current management of seizures at the end of life utilises sedating medications
(midazolam and phenobarbital) administered via the subcutaneous route. The …
(midazolam and phenobarbital) administered via the subcutaneous route. The …